To study the role of homoeopathic medicines in cases of eczema

A clinical study to assess the effectiveness of individualised Homoeopathic medicine in cases of Eczema - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068342

Enrollment

Registered

2024-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine selected on the basis of totality of symptoms Doses based on the Susceptibility of the patients in 30,200 or 1

Eligibility

Inclusion criteria

Inclusion criteria: I. Samples of both sexes and all ages will be taken. II. Cases of chronic eczema will be taken.

Exclusion criteria

Exclusion criteria: I. Life-threatening complications are excluded in this study. II. Patient with immune compromised are excluded in this study. III. Pregnant and lactating females are excluded in this study. IV. Patient with other skin diseases with same manifestation are excluded. v. case with irregular follow up.

Design outcomes

Primary

Measure	Time frame
To Assess The Effectiveness Of Individualized Homoeopathic Medicine In Case Of EczemaTimepoint: 12 Weeks, 24 Weeks	—

Secondary

Measure	Time frame
To Check The Patients Response To The MedicineTimepoint: 12 Weeks, 24 Weeks	—

Countries

India

Contacts

Public ContactDr komalben Dilipsinh Vansadiya

Rajkot Homoeopathic Medical College Parul University

shailendra.bhamar17970@paruluniversity.ac.in9737461271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026